1. The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?
- Author
-
Luís Campos Pinheiro, João Tiago Guimarães, Stefan Holdenrieder, Ruy M. Ribeiro, Manuel M Garrido, Repositório da Universidade de Lisboa, and Instituto de Saúde Pública da Universidade do Porto
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Prostate biopsy ,Biopsy ,Clinical Biochemistry ,Clinically significant prostate cancer ,Urology ,Biochemistry ,Prostatic Neoplasms* / diagnosis ,CHLC PAT CLIN ,03 medical and health sciences ,Prostate cancer ,Health index ,0302 clinical medicine ,Antigen ,Prostate ,Prostate health index ,medicine ,Humans ,Overdiagnosis ,Prostate-specific antigen density ,Prostate-Specific Antigen ,medicine.diagnostic_test ,business.industry ,Biochemistry (medical) ,Area under the curve ,Prostatic Neoplasms ,General Medicine ,medicine.disease ,Prostate-specific antigen ,030104 developmental biology ,medicine.anatomical_structure ,Area Under Curve ,030220 oncology & carcinogenesis ,Prostate health index density ,business ,HSJ URO - Abstract
Copyright © 2021 Elsevier B.V. All rights reserved., Background and aims: Overdiagnosis of prostate cancer (PCa) should be minimized. We wanted to evaluate the diagnostic performance of the prostate health index density (PHID) and compare it with that of the prostate health index (PHI) alone and of the prostate-specific antigen density (PSAD). Materials and methods: 232 men scheduled for a prostate biopsy (prostate-specific antigen level: 2-10 µg/L), were enrolled. PHI, PHID and PSAD were evaluated considering PCa and clinically significant PCa (csPCa) as the outcomes. Results: For PCa, the area under the curve (AUC) was higher for PHID (0.823) than for PHI (0.779) and PSAD (0.776). For csPCa, the AUC was also higher for PHID (0.851) but closer to that of PSAD (0.819) and PHI (0.813). For equal sensitivities (90%) for PCa, PHID and PSAD offered the highest specificities (37%), missing the same number of cancers (n=11). Considering csPCa, PHI and PHID had similar specificities. PSAD reached the highest specificity (50.0%), sparing 32.8% of biopsies, while missing 9 cases of csPCa. Conclusions: PHID has a better diagnostic performance than PHI for overall PCa detection, but very close to the PSAD performance. Considering csPCa, PHI and PHID perform almost equally, but PSAD has a better diagnostic performance.
- Published
- 2021
- Full Text
- View/download PDF